Connect with us

Japan

Japanese Mitsuoka Motors may move auto production base to Thailand

Mitsuoka Motors, a small Japanese automobile company which has had a Thai presence for the past two years, is considering moving its production base to the Kingdom. Although details are currently scarce, the production site is most likely to be the Yontrakit production facility in Lat Krabang district.

Published

on

Mitsuoka Motors, a small Japanese automobile company which has had a Thai presence for the past two years, is considering moving its production base to the Kingdom. Although details are currently scarce, the production site is most likely to be the Yontrakit production facility in Lat Krabang district.

Read the original article:
Mitsuoka may move auto production base to Thailand

The market’s views on export performance in 2010 of Thailand have improved
The key risk to the global recovery lies in the need to get the timing of withdrawing fiscal and monetary stimulus just right. Withdrawal of fiscal stimulus too early may lead to another negative demand shock and a negative expectations spiral, whereas withdrawing the stimulus too late may lead to high inflation, further weakening of the US dollar, and possible asset price bubbles. In Thailand, for example, more than ten years since the 1997/1998 financial crisis banks still have bad loans in their books and the government still holds a large amount of debt related to the recapitalization of financial institutions. Given the expected length of recovery, it is important not to withdraw stimulus programs too soon, before the recovery is on a firm footing. On the other hand, macroeconomic imbalances are accumulating and eventually fiscal and monetary authorities, especially in the US, must consolidate their fiscal position and withdraw liquidity.

Most of the infrastructure development in Thailand has been responsive to demand rather than forward-looking. Availability and accessibility appear to no longer be a challenge. The next step for Thailand is to put more emphasis on quality of service delivery, management, and sound regulation.

Asean

ASEAN, Japan reaffirm commitment to advance partnership

Published

on

ASEAN, Japan reaffirm commitment to advance partnership

JAKARTA, 23 March 2020- The 15th ASEAN-Japan Joint Cooperation Committee Meeting took place virtually today, underscoring the commitment of both sides to further strengthen the ASEAN-Japan partnership.

(more…)
Continue Reading

Japan

Japan launches COVID-19 vaccinations as Olympics approach

The country has been slow to launch vaccinations against the coronavirus, starting its program later than around 80 other countries as Prime Minister Yoshihide Suga faces criticism of a sluggish pandemic response.

Published

on

Japan launches COVID-19 vaccinations as Olympics approach

Japan began administering COVID-19 vaccine on Wednesday, starting with hospital staff in the Tokyo metropolitan area before expanding the rollout nationwide as the clock ticks down to the Summer Olympics and Paralympics.

The country has been slow to launch vaccinations against the coronavirus, starting its program later than around 80 other countries as Prime Minister Yoshihide Suga faces criticism of a sluggish pandemic response.

Kazuhiro Araki (L), head of the Tokyo Medical Center, is administered a COVID-19 vaccine at his hospital in Tokyo’s Meguro Ward on Feb. 17, 2021, receiving the first shot under Japan’s vaccination program against the novel coronavirus. Japan is starting with an initial group of 40,000 health workers before expanding the rollout to the elderly and people with preexisting conditions. (Pool photo) (Kyodo) ==Kyodo

A total of 125 staff members were inoculated at eight hospitals in and around the capital on Wednesday, with the vaccine developed by U.S. drugmaker Pfizer Inc. and Germany’s BioNTech SE due to be administered at 100 medical facilities across the country by next week.

Speaking in a parliamentary committee meeting, Suga reiterated that vaccines will be the “decisive factor” in fighting the coronavirus and vowed to move forward with the rollout while keeping the public informed.

Of the initial group of 40,000 health workers, 20,000 will participate in a study to track side effects potentially caused by the vaccine and the frequency with which they occur. They will be asked to keep daily records for seven weeks after taking the first of two shots. The shots will be administered three weeks apart.

A health worker injects COVID-19 vaccine from a bottle into a syringe at the Tokyo Medical Center in Tokyo’s Meguro Ward on Feb. 17, 2021. Japan began COVID-19 vaccinations the same day, with the first shots given at the state-run hospital. (Pool photo) (Kyodo) ==Kyodo

Twelve staffers, including three doctors and five nurses, were inoculated at the state-run Tokyo Medical Center on Wednesday. Hospital head Kazuhiro Araki, who was first in the country to receive the shot, said he hopes participating in the study will “help both staff and patients prevent infections.”

No severe side effects were immediately reported from any of the eight hospitals.

A further 3.7 million front-line health workers are to begin being inoculated in March, followed by 36 million people aged 65 or older from April.

Related coverage:

Japan to start COVID-19 vaccination of 40,000 health workers Wed.

Japan may delay COVID-19 timetable for inoculating elderly

Dry ice makers scramble to meet vaccine-driven demand surge

People with preexisting conditions such as diabetes or heart disease and those working at elderly care facilities will come next, and then finally the general population.

Japan is starting its vaccine rollout more than two months after Britain and the United States. Asked in the House of Representative’s Budget Committee session about the cause of the delay, Suga accepted the criticism and admitted that the need to conduct clinical trials domestically had held up the process.

The minister in charge of vaccination efforts, Taro Kono, said Tuesday that foreign residents will become eligible for the free shots in the same order of priority as Japanese citizens.

Japan received the first shipment of about 386,000 doses from Pfizer’s factory in Belgium last week and granted fast-track approval for domestic use on Sunday.

Kono said at a press conference that the second shipment had been cleared by the European Union under its new vaccine export controls and was expected to arrive next week but declined to say how many doses it would contain.

Late-stage clinical trials showed the Pfizer vaccine to have an efficacy rate of around 95 percent, compared with 40 to 60 percent for influenza vaccines. Japan also has supply deals with AstraZeneca Plc and Moderna Inc. to receive enough doses for its population of 126 million.

But public skepticism could be a hurdle for Japan’s vaccine rollout, with only 63.1 percent of respondents in a…

Source link

Continue Reading

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 14,165 other subscribers

Wise

Recent